T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease.
Saved in:
| Title: | T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease. |
|---|---|
| Authors: | Rahmani F; Washington University School of Medicine, St. Louis, Missouri, USA., Brier MR; Washington University School of Medicine, St. Louis, Missouri, USA., Gordon BA; Washington University School of Medicine, St. Louis, Missouri, USA., McKay N; Washington University School of Medicine, St. Louis, Missouri, USA., Flores S; Washington University School of Medicine, St. Louis, Missouri, USA., Keefe S; Washington University School of Medicine, St. Louis, Missouri, USA., Hornbeck R; Washington University School of Medicine, St. Louis, Missouri, USA., Ances B; Washington University School of Medicine, St. Louis, Missouri, USA., Joseph-Mathurin N; Washington University School of Medicine, St. Louis, Missouri, USA., Xiong C; Washington University School of Medicine, St. Louis, Missouri, USA., Wang G; Washington University School of Medicine, St. Louis, Missouri, USA., Raji CA; Washington University School of Medicine, St. Louis, Missouri, USA., Libre-Guerra JJ; Washington University School of Medicine, St. Louis, Missouri, USA., Perrin RJ; Washington University School of Medicine, St. Louis, Missouri, USA., McDade E; Washington University School of Medicine, St. Louis, Missouri, USA., Daniels A; Washington University School of Medicine, St. Louis, Missouri, USA., Karch C; Washington University School of Medicine, St. Louis, Missouri, USA., Day GS; Mayo Clinic, Department of Neurology, Jacksonville, Florida, USA., Brickman AM; Taub Institute for Research on Alzheimer's Disease & the Aging Brain, and Department of Neurology College of Physicians and Surgeons, Columbia University, New York, New York, USA., Fulham M; Royal Prince Alfred Hospital (RPA), Sydney, Australia., Jack CR Jr; Mayo Clinic, Rochester, Minnesota, USA., la La Fougère C; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE) Tuebingen, Tübingen, Germany.; Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Reischl G; Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE) Tuebingen, Tübingen, Germany.; Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany., Schofield PR; Neuroscience Research Australia, Sydney, New South Wales, Australia.; School of Biomedical Sciences, University of New South Wales, Sydney, New South Wales, Australia., Oh H; Brown University, Providence, Rhode Island, USA., Levin J; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), site Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Vöglein J; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), site Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Cash DM; UK Dementia Research Institute at University College London, London, UK.; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK., Yakushev I; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), site Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Ikeuchi T; Niigata University, Brain Research Institute, Niigata, Japan., Klunk WE; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Morris JC; Washington University School of Medicine, St. Louis, Missouri, USA., Bateman RJ; Washington University School of Medicine, St. Louis, Missouri, USA., Benzinger TLS; Washington University School of Medicine, St. Louis, Missouri, USA. |
| Corporate Authors: | Dominantly Inherited Alzheimer Network (DIAN) |
| Source: | Human brain mapping [Hum Brain Mapp] 2023 Dec 15; Vol. 44 (18), pp. 6375-6387. Date of Electronic Publication: 2023 Oct 23. |
| Publication Type: | Observational Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 9419065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0193 (Electronic) Linking ISSN: 10659471 NLM ISO Abbreviation: Hum Brain Mapp Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0193 |
|---|---|
| DOI: | 10.1002/hbm.26514 |
